Merck & Co (NYSE: MRK) says it has formed a new joint venture with Supera Farma Laboratorios, a Brazilian drugmaker co-owned by Cristalia and Eurofarma, to mark 16 February 2012
In a regulatory filing with the Hong Kong Stock Exchange yesterday, Shanghai Pharmaceuticals Holding (SHSE: 601607) says it has resolved to gain control of Chan 7 February 2012
Icelandic generics drugmaker Actavis and Polandâs Bioton (WSE: BIO) have formed a joint venture company for the development and registration of insulins, incl 31 January 2012
German drugmakers STADA Arzneimittel (SAZ: GR) and family-owned Grunenthal have agreed on the purchase of a branded product portfolio including the associated s 30 January 2012
US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) has kicked off the new year with the acquisition of Ascent Pharmahealth, the Australia and Southeast Asi 24 January 2012
Fast-growing Jordan headquartered Hikma Pharmaceuticals (LSE: HIK) says that it has increased its stake in Morocco-based Promopharm (Societe de Promotion Pharma 22 January 2012
Indian drugmaker Dishman Pharmaceuticals and Chemicals says that its Swiss unit has acquired a contract research and manufacturing firm from France-based Creaph 17 January 2012
Danish CNS drug specialist Lundbeck (LUND: DC) says it has entered into an agreement with USA-based niche generic drugmaker Akorn (Nasdaq: AKRX) to sell a portf 23 December 2011
Miami, USA-based OPKO Health (NYSE: OPK), which is controlled by Israeli generics giant Teva Pharmaceutical Industries (Nasdaq: TEVA), has entered into an agree 22 December 2011
Indian drug firm Zydus Cadila says it has acquired a 100% stake in Biochem, described as one of the top 40 pharma companies in India, for an undisclosed amount. 21 December 2011
Swiss branded and generic drugmaker Acino Pharma (SIX: ACIN) and Israelâs Teva Pharmaceutical Industries (Nasdaq: TEVA) have entered into an agreement for Aci 19 December 2011
US medical products and generic drugmaker Covidien (NYSE: COV) says that it plans to spin off its pharmaceuticals business - which generates around $2 billion i 16 December 2011
It was a busy couple of days for Anglo-Swedish drug major AstraZeneca (LSE: AZN), with the company yesterday announcing a new set of cutbacks in the number of U 8 December 2011
The generic drugs sectorâs role as the provider of affordable drugs has widely benefitted public and private health payers keen to control costs. But in the c 7 December 2011
Iceland-headquartered generic drugmaker Actavis says it has acquired 100% of the shares in PharmaPack International BV for an undisclosed amount. PharmaPack is 4 December 2011
California, USA-based generic drugmaker SOHM (Pinksheets: SHMN) has announced the acquisition of business and brands of privately owned Novatrend Medicament, a 28 November 2011
Indian drugmaker Lupin (LOPN: BO) has entered into an agreement with Japanese health care provider Iârom Holdings (IH) to acquire up to 100% of the outstandin 18 November 2011
German drugmaker STADA Arzneimittel (SAZ: GR) has reached agreement with Switzerlandâs Spirig Pharma to purchase Spirig's generics business including the resp 11 November 2011
Chinese drugmaker Biostar Pharmaceuticals (Nasdaq: BSPM) says that it has completed the previously-announced acquisition of Shaanxi Weinan Huaren Pharmaceutical 25 October 2011
Indian drugmaker Sun Pharmaceuticals (SUN: BO) has proposed to acquire the remaining shares of Israel-based Taro Pharmaceutical (Pink Sheets: TAROF) for $24.50/ 20 October 2011
USA-based Insmed (NASDAQ CM: INSM) is a biopharmaceutical company on the development and commercialization of novel, targeted inhaled therapies for patients with serious rare diseases.
Sign up to receive email updates Join industry leaders for a daily roundup of biotech & pharma news